LONDON, Aug. 16, 2022 /PRNewswire/ — Virax Biolabs (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Chairman of the Board and Chief Executive Officer, James Foster…

Generated by Feedzy